European Commission approves lecanemab for treatment of early Alzheimer’s disease
European Commission approves lecanemab for treatment of early Alzheimer’s disease In a landmark decision, the European Commission has granted EU-wide authorisation for lecanemab, the first medicine to treat mild cognitive […]